Global Smart Inhalers Market 2022-2028

The global smart inhalers market size is projected to grow by USD 536 million from 2022 to 2028, registering a CAGR of 21.7 percent.

Inhalers are used to treat chronic obstructive pulmonary disease (COPD), such as asthma, by delivering bronchodilator medication to the airway directly, without passing through the blood. A smart inhaler is an inhaler that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use. The global smart inhalers market size is projected to grow by USD 536 million from 2022 to 2028, registering a CAGR of 21.7 percent, according to a new report The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global smart inhalers market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the smart inhalers industry.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, disorder, and region. The global market for smart inhalers can be segmented by product: dry powder inhaler (DPI)-based smart inhalers , metered-dose inhaler (MDI)-based smart inhalers. Among these, the MDI-based smart inhalers segment was accounted for the highest revenue generator in 2021. Smart inhalers market is further segmented by disorder: asthma, chronic obstructive pulmonary disease (COPD). The asthma segment is estimated to account for the largest share of the global smart inhalers market. Based on region, the smart inhalers market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). Europe held the largest share of the global smart inhalers market in 2021 and is anticipated to hold its share during the forecast period. By product: - dry powder inhaler (DPI)-based smart inhalers - metered-dose inhaler (MDI)-based smart inhalers By disorder: - asthma - chronic obstructive pulmonary disease (COPD)

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

By region: - Asia Pacific - Europe - North America - Rest of the World (RoW) The report has also analysed the competitive landscape of the global smart inhalers market with some of the key players being AstraZeneca plc, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc (GSK), Heitkamp & Thumann KG, Novartis International AG, OPKO Health, Inc. (OPK), Teva Pharmaceutical Industries Ltd., Vectura Group plc, among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

Scope of the Report - To analyze and forecast the market size of the global smart inhalers market. - To classify and forecast the global smart inhalers market based on product, disorder, region. - To identify drivers and challenges for the global smart inhalers market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global smart inhalers market. - To identify and analyze the profile of leading players operating in the global smart inhalers market. Why Choose This Report - Gain a reliable outlook of the global smart inhalers market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.

Table of Contents

  • TABLE OF CONTENTS
  • FIGURES AND TABLES
  • PART 1. INTRODUCTION
  • · Report description
  • · Objectives of the study
  • · Market segment
  • · Years considered for the report
  • · Currency
  • · Key target audience
  • PART 2. METHODOLOGY
  • PART 3. EXECUTIVE SUMMARY
  • PART 4. MARKET OVERVIEW
  • · Introduction
  • · Drivers
  • · Restraints
  • · Impact of COVID-19 pandemic
  • PART 5. MARKET BREAKDOWN BY PRODUCT
  • · Dry powder inhaler (DPI)-based smart inhalers
  • · Metered-dose inhaler (MDI)-based smart inhalers
  • PART 6. MARKET BREAKDOWN BY DISORDER
  • · Asthma
  • · Chronic obstructive pulmonary disease (COPD)
  • PART 7. MARKET BREAKDOWN BY REGION
  • · Asia Pacific
  • · Europe
  • · North America
  • · Rest of the World (RoW)
  • PART 8. KEY COMPANIES
  • · AstraZeneca plc
  • · Boehringer Ingelheim International GmbH
  • · GlaxoSmithKline plc (GSK)
  • · Heitkamp & Thumann KG
  • · Novartis International AG
  • · OPKO Health, Inc. (OPK)
  • · Teva Pharmaceutical Industries Ltd.
  • · Vectura Group plc
  • *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
  • DISCLAIMER

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Global Smart Inhalers Market 2022-2028

We are friendly and approachable, give us a call.